Company: DARE
Filing Date: 2025-07-21
Form Type: 8-K
Source: 0001641172-25-020295
Chunk: 0

Company: Dare Bioscience, Inc.
Filing Date: 2025-07-21
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01 Other Events.

Based on sales of shares of its common stock under its “at-the-market,” or ATM, equity offering program and equity line
arrangement since March 31, 2025 through July 18, 2025 resulting in gross proceeds of approximately $16.5 million, and after
considering anticipated losses through July 18, 2025, as of the date of this report, Daré Bioscience, Inc.
(“ Daré,” “we,” “us,” “our” or the “ Company”) believes its
stockholders’ equity is in excess of the $2.5 million minimum required under Nasdaq Listing Rule 5550(b)(1), and intends to
notify Nasdaq of the foregoing so that Nasdaq can make a determination as to whether the Company has regained compliance with
requirements for continued listing. There can be no assurance that the Nasdaq will determine that the Company has regained
compliance with such requirements.

As
previously reported, the Company has not been in compliance with Nasdaq Listing Rule 5550(b) since August 2024. Nasdaq Listing Rule 5550(b)(1)
requires a company to maintain stockholders’ equity of at least $2.5 million, and Nasdaq Listing Rule 5550(b)(2) requires a company
to maintain a minimum market value of listed securities of $35.0 million. A company will satisfy the continued listing requirement under
Nasdaq Listing Rule 5550(b) if it meets either Nasdaq Listing Rule 5550(b)(1) or (2).

After taking into account the
sale of shares of common stock described above, there will be approximately 12.6 million shares of common stock outstanding.

Forward-Looking
Statements

Daré
cautions you that all statements, other than statements of historical facts, contained in this report, are forward-looking statements.
Forward-looking statements, in some cases, can be identified by terms such as “believe,” “may,” “will,”
“estimate,” “continue,” “anticipate,” “design,” “intend,” “expect,”
“could,” “plan,” “potential,” “predict,” “seek,” “should,” “would,”
“contemplate,” “project,” “target,” “objective,” “on track,” or the negative
version of these words and similar expressions. In this report, forward-looking statements include, but are not limited to, statements
rel